Gretchen White, PhD, MPH

  • Associate Professor of Medicine, Epidemiology, and Clinical and Translational Science
  • Electus Faculty Fellow, David C. Frederick Honors College

Dr. Gretchen White's research focuses on obesity, alcohol and substance use, and career development of health researchers. Dr. White has served as MPI or co-investigator on multiple NIH-funded studies. She uses her epidemiological training in the design, conduct, and analysis of randomized controlled trials and cohort studies to collaborate with other researchers and as a mentor on career development awards.

Dr. White lives in Mt. Lebanon with her husband and two children. In her spare time, she can be found gardening, baking elaborate gluten-free confections, or following college basketball.

Education & Training

  • BA (Psychology), Providence College, 2066
  • MPH (Epidemiology), Drexel University, 2009
  • Public Health Fellowship, Association of the Schools of Public Health/Centers for Disease Control and Prevention, 2011
  • PhD, Epidemiology, University of Pittsburgh, 2018

Representative Publications

White GE, Courcoulas AP, King WC. Drug- and alcohol-related mortality risk after bariatric surgery: Evidence from a 7-year prospective multicenter cohort study. Surg Obes Relat Dis. 2019;15(7):1160-1169.

This study demonstrated that drug- and alcohol-related mortality is significantly higher than expected in the 7 years following metabolic and bariatric surgery.

White GE, Shu I, Rometo D, Arnold J, Korytkowski M, Luo J. Real-world weight loss effectiveness of GLP-1 agonists among patients with type 2 diabetes: a retrospective cohort study. Obesity (Silver Spring). 2023;31(2):537-544.

This retrospective cohort study of more than 2400 patients with overweight or obesity and type 2 diabetes showed that starting a GLP-1 agonist at standard glycemic control doses was associated with modest weight loss.

White GE, Boles RE, Courcoulas AP, Yanovski SZ, Zeller MH, Jenkins TM, Inge TH. A prospective cohort of alcohol use and alcohol-related problems before and after metabolic and bariatric surgery in adolescents. Ann Surg. 2023;278(3):e519-e525.

Longitudinal analysis showing that nearly half of those who underwent metabolic and bariatric surgery as adolescents screened positively for Alcohol Use Disorder, symptoms of alcohol-related harm, or alcohol-related problems 8 years post-surgery, highlighting the risk for alcohol use and Alcohol Use Disorder after metabolic and bariatric surgery during adolescence. 

Mayowski C, Meagher EA, Althouse AD, Patino-Sutton C, Thakar MS, Welch JL, Rubio DM, White GE. Continued impact of COVID-19 pandemic on clinical and translational science early-career researchers. J Clin Transl Sci. 2023; 7(1):e7.

Findings from this cluster-randomized controlled trial showed that the effects of the pandemic on early-career health researchers may be prolonged.

Click here for a more complete bibliography of Dr. White’s works.

Research Interests

  • Career development
  • Obesity
  • Alcohol and substance use disorders
  • Randomized controlled trials
  • Longitudinal data analyses